1. Home
  2. UTHR vs WSM Comparison

UTHR vs WSM Comparison

Compare UTHR & WSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UTHR
  • WSM
  • Stock Information
  • Founded
  • UTHR 1996
  • WSM 1956
  • Country
  • UTHR United States
  • WSM United States
  • Employees
  • UTHR N/A
  • WSM N/A
  • Industry
  • UTHR Biotechnology: Pharmaceutical Preparations
  • WSM Home Furnishings
  • Sector
  • UTHR Health Care
  • WSM Consumer Discretionary
  • Exchange
  • UTHR Nasdaq
  • WSM Nasdaq
  • Market Cap
  • UTHR 20.7B
  • WSM 24.8B
  • IPO Year
  • UTHR 1999
  • WSM N/A
  • Fundamental
  • Price
  • UTHR $448.47
  • WSM $189.23
  • Analyst Decision
  • UTHR Buy
  • WSM Buy
  • Analyst Count
  • UTHR 15
  • WSM 16
  • Target Price
  • UTHR $459.60
  • WSM $199.13
  • AVG Volume (30 Days)
  • UTHR 846.4K
  • WSM 1.1M
  • Earning Date
  • UTHR 10-29-2025
  • WSM 11-19-2025
  • Dividend Yield
  • UTHR N/A
  • WSM 1.40%
  • EPS Growth
  • UTHR 17.94
  • WSM 9.54
  • EPS
  • UTHR 25.63
  • WSM 9.01
  • Revenue
  • UTHR $3,077,800,000.00
  • WSM $7,829,759,000.00
  • Revenue This Year
  • UTHR $13.71
  • WSM $2.64
  • Revenue Next Year
  • UTHR $5.72
  • WSM $3.22
  • P/E Ratio
  • UTHR $17.38
  • WSM $20.97
  • Revenue Growth
  • UTHR 17.62
  • WSM 3.28
  • 52 Week Low
  • UTHR $266.98
  • WSM $125.33
  • 52 Week High
  • UTHR $459.48
  • WSM $219.98
  • Technical
  • Relative Strength Index (RSI)
  • UTHR 65.25
  • WSM 40.70
  • Support Level
  • UTHR $415.00
  • WSM $191.38
  • Resistance Level
  • UTHR $459.40
  • WSM $203.71
  • Average True Range (ATR)
  • UTHR 13.47
  • WSM 4.80
  • MACD
  • UTHR -1.34
  • WSM -1.19
  • Stochastic Oscillator
  • UTHR 71.49
  • WSM 9.40

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

About WSM Williams-Sonoma Inc. (DE)

With a retail and direct-to-consumer presence, Williams-Sonoma is a player in the $300 billion domestic home category and $450 billion international home market, focused on expanding its exposure in the B2B ($80 billion total addressable market), marketplace, and franchise areas. Namesake Williams-Sonoma (154 stores) offers high-end cooking essentials, while Pottery Barn (181) provides casual home accessories. West Elm (119) is an emerging concept for young professionals, and Rejuvenation (11) offers lighting and house parts. Brand extensions include Pottery Barn Kids and Pottery Barn Teen (44) as well as Mark & Graham and GreenRow. Williams-Sonoma also has a business-to-business team that supports projects that range from residential to large-scale commercial.

Share on Social Networks: